Yd Biopharma Limited (YDES)

$12.50 +4.50 (56.25%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -7,451.52%
Debt to Equity Ratio 0.92
Volume 916,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Industry: Biotechnology
Sector: Healthcare
Address:
No. 3, Xingnan St., 12F. Nangang Dist., Taipei, Taiwan
nebius
nebius Jun. 16 at 10:43 AM
$YDES $4.5 today
0 · Reply
LeVitoQuantum
LeVitoQuantum Jun. 7 at 10:52 AM
$YDES Relatively unknown ticker, could spark 50-200% out of nowhere.
0 · Reply
ChewyTrader
ChewyTrader Jun. 7 at 10:51 AM
$YDES Low watcher count, I see high potential here.
0 · Reply
topstockalerts
topstockalerts Jun. 4 at 12:43 AM
$YDES just watching how it reacts here… key spot
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 7 at 2:41 AM
$YDES
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 2 at 12:38 PM
$YDES Current Stock Price: $8.76
0 · Reply
NetWorthNexus
NetWorthNexus Feb. 4 at 3:34 PM
$YDES is a clothing retailer or brand; its performance is tied to fashion trends, consumer discretionary spending, and retail execution.
0 · Reply
DARKP00L
DARKP00L Jan. 29 at 11:16 PM
$YDES
0 · Reply
tplayer259
tplayer259 Jan. 29 at 6:21 PM
$YDES is this trading lower on the news of the latest acquisition because they will be issuing new shares to the new companies owners?
0 · Reply
DARKP00L
DARKP00L Jan. 29 at 5:53 PM
$YDES
0 · Reply
Latest News on YDES
YD Bio Limited Reports Full Year 2025 Financial Results

Apr 30, 2026, 6:00 PM EDT - 7 weeks ago

YD Bio Limited Reports Full Year 2025 Financial Results

YDES

YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States

Mar 31, 2026, 8:00 AM EDT - 3 months ago

YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States

YDES

YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem

Mar 17, 2026, 8:00 AM EDT - 3 months ago

YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem

YDES

YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform

Feb 25, 2026, 8:00 AM EST - 4 months ago

YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform

YDES

YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy

Jan 29, 2026, 8:30 AM EST - 5 months ago

YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy

YDES

YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development

Jan 6, 2026, 9:00 AM EST - 6 months ago

YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development

YDES

YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap

Jan 5, 2026, 9:00 AM EST - 6 months ago

YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap

YDES

YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center

Dec 16, 2025, 9:00 AM EST - 6 months ago

YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center

YDES

YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN

Dec 9, 2025, 9:00 AM EST - 7 months ago

YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN

YDES

YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection

Dec 2, 2025, 9:00 AM EST - 7 months ago

YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection

YDES

YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics

Nov 24, 2025, 9:00 AM EST - 7 months ago

YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics

YDES

YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring

Nov 5, 2025, 8:30 AM EST - 8 months ago

YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring

YDES

YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES

Oct 20, 2025, 10:20 AM EDT - 8 months ago

YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES

YDES

YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities

Oct 10, 2025, 8:37 AM EDT - 9 months ago

YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities

YDES

YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

Sep 30, 2025, 5:25 PM EDT - 9 months ago

YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

YDES

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

Aug 29, 2025, 7:30 AM EDT - 10 months ago

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

YDES

nebius
nebius Jun. 16 at 10:43 AM
$YDES $4.5 today
0 · Reply
LeVitoQuantum
LeVitoQuantum Jun. 7 at 10:52 AM
$YDES Relatively unknown ticker, could spark 50-200% out of nowhere.
0 · Reply
ChewyTrader
ChewyTrader Jun. 7 at 10:51 AM
$YDES Low watcher count, I see high potential here.
0 · Reply
topstockalerts
topstockalerts Jun. 4 at 12:43 AM
$YDES just watching how it reacts here… key spot
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 7 at 2:41 AM
$YDES
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 2 at 12:38 PM
$YDES Current Stock Price: $8.76
0 · Reply
NetWorthNexus
NetWorthNexus Feb. 4 at 3:34 PM
$YDES is a clothing retailer or brand; its performance is tied to fashion trends, consumer discretionary spending, and retail execution.
0 · Reply
DARKP00L
DARKP00L Jan. 29 at 11:16 PM
$YDES
0 · Reply
tplayer259
tplayer259 Jan. 29 at 6:21 PM
$YDES is this trading lower on the news of the latest acquisition because they will be issuing new shares to the new companies owners?
0 · Reply
DARKP00L
DARKP00L Jan. 29 at 5:53 PM
$YDES
0 · Reply
DARKP00L
DARKP00L Jan. 29 at 1:45 PM
$YDES 08:41 on Jan. 29 2026 YD Bio Limited Signs Binding LOI To Acquire Safe Save Medical Cell Sciences & Technology; Co Intends To Acquire 100% Of Equity Interest For Consideration Of $26.87M #tradeideas
0 · Reply
ZacksSCR
ZacksSCR Jan. 13 at 8:07 PM
$YDES: YD Biopharma Is An Integrated Biotechnology Company That Is Poised To Have A Transformational Year As It Expands Business Operations https://buff.ly/N2Wf4vW
0 · Reply
BioTuesdays
BioTuesdays Jan. 7 at 6:29 PM
$YDES has announced that it has entered into a Memorandum of Understanding (MOU) to merge with closely held EG BioMed—a biotechnology company specializing in DNA methylation–based cancer diagnostics and AI-driven biomarker analytics https://biotuesdays.com/2026/01/07/yd-bio-enters-mou-to-merge-with-eg-biomed/
0 · Reply
ZacksSCR
ZacksSCR Jan. 7 at 3:06 PM
$YDES is A Biotechnology Company on the Move https://buff.ly/N2Wf4vW
0 · Reply
DARKP00L
DARKP00L Jan. 6 at 7:13 PM
$YDES 13:59 on Jan. 06 2026 YD Bio shares are trading lower. The company announced that it has entered into a Memorandum of Understanding to merge with EG BioMed. #tradeideas
0 · Reply
Stockships
Stockships Jan. 6 at 1:14 AM
$YDES ROUND 2 😱😱😱 ON another setup... It’s happening again. If you caught $CABR today, you’ll want eyes on Y-D-E-S next. This setup is even stronger — with 90+ months of cash on hand. Yes, you read that right. The stats above speak loud and clear. Buckle up. Y-D-E-S is coiled and ready to explode. 🚀 WHO KNOWS WHAT WILL HAPPEN 🤫🤫🤫... Stockships.com/disclaimer
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 24 at 11:01 AM
$YDES Current Stock Price: $12.00
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 19 at 9:49 AM
$YDES Current Stock Price: $11.31
0 · Reply